Details for Patent: 6,248,735
✉ Email this page to a colleague
Summary for Patent: 6,248,735
Title: | Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a .beta.-adrenergic antagonist |
Abstract: | Combinations of a .beta.-adrenergic antagonist and a topical carbonic anhydrase inhibitor are particularly useful in the treatment of ocular hypertension, especially in patients insufficiently responsive to treatment with .beta.-adrenergic antagonists. |
Inventor(s): | Baldwin; John J. (Gwynedd Valley, PA) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 08/833,067 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 6,248,735
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,248,735
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0509752 | ⤷ Sign Up | CA 2000 00002 | Denmark | ⤷ Sign Up |
European Patent Office | 0509752 | ⤷ Sign Up | C990041 | Netherlands | ⤷ Sign Up |
European Patent Office | 0509752 | ⤷ Sign Up | SPC/GB99/043 | United Kingdom | ⤷ Sign Up |
European Patent Office | 0509752 | ⤷ Sign Up | 2000C/001 | Belgium | ⤷ Sign Up |
European Patent Office | 0509752 | ⤷ Sign Up | 49/1999 | Austria | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |